Egypt-based life science startup Nawah Scientific has sold a strategic stake to Essam Abdelhadi, the former vice president Middle East, Turkey, Africa and Pakistan of Abbott, a US-based healthcare multinational, ahead of its upcoming Series A round. Founded in 2015, Nawah Scientific is an online platform that receives experiment requests, collects samples, conducts tests and returns results digitally. Its aim is to enable scientists to conduct higher quality research, regardless of their location and owned lab facilities. The startup has established itself as an integral part of Egypt’s pharmaceutical industry and has so far analysed over 50,000 samples from more than 3,000 clients in nine countries. Having concluded a US$1 million pre-Series A round earlier in the year, Nawah Scientific is now working on a Series A, and has part of that has secured backing from Abdelhadi and added him to its advisory board. The startup recently expanded to Jordan and is also growing its offerings to pharmaceutical companies to include formulation development, stability studies, as well as all raw material and finished products quality control checks.
SOURCE: DISRUPT AFRICA
More Stories
Tinubu Hits the Ground Running
Russian Minister Makes a Quick Stop in Nairobi
Four Men Absolved of Drug Trafficking in Liberia Disappear
Governments in Sub-Saharan Africa Struggle to Regulate the Mass Expansion of Online Gambling
Why Returns from European Countries are Hugely Unpopular in Most African Countries
A $3 billion IMF Bailout Will Not Instantly Solve Ghana’s Economic Problems
Can Kenya Successfully Establish Efficient and Affordable Smartphone Manufacturing?
How to Be a Female Politician in Africa
Egyptian Firm Unveils IoT-enabled Smartwatch
Women at the Forefront of Africa’s Peace Efforts
With ‘Banel & Adama,’ Ramata-Toulaye Sy Takes Her Place Among Cannes’ Top Names
The Lion Sleeps Tonight: One Song’s Journey from 1930s South Africa to Disney Money-Spinner